HIV-associated large-vessel vasculopathy: A review of the current and emerging clinicopathological spectrum in vascular surgical practice

Cardiovascular Journal of Africa

Volumn 26, Issue 2, 2014, Pages 70-81

  Pillay, Balasoobramanien ^a   Ramdial, Pratistadevi K ^b   Naidoo, Datshana P ^b  

^a UNIVERSITY OF KWAZULU NATAL   (South Africa)

^b UNIVERSITY OF KWAZULU NATAL   (South Africa)

Author keywords

Aneurysms; Atherosclerosis; Human immunodeficiency virus; Occlusive disease; Vascular surgery; Vasculopathy

Indexed keywords

ANTIRETROVIRUS AGENT; ANTITHROMBIN III; COBALAMIN; DACLIZUMAB; FOLIC ACID; GLYCOPROTEIN; GLYCOPROTEIN GP120; GLYCOPROTEIN GP41; INTERLEUKIN 1; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 6; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; PROTEIN C; PROTEIN S; PROTEINASE INHIBITOR; STEROID; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ANGIOGRAPHY; ARTERIOVENOUS FISTULA; ARTERY DISSECTION; ARTERY OCCLUSION; ATHEROSCLEROSIS; BLOOD VESSEL INJURY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CAROTID ARTERY ANEURYSM; CD4 CD8 RATIO; CLINICAL FEATURE; CORONARY ARTERY CALCIUM SCORE; CYANOCOBALAMIN DEFICIENCY; DEEP VEIN THROMBOSIS; EMBOLECTOMY; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM INJURY; FOLIC ACID DEFICIENCY; GRAFT OCCLUSION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HIV ASSOCIATED NEPHROPATHY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIFESTYLE MODIFICATION; LIMB SALVAGE; LONG TERM SURVIVAL; LONGEVITY; NECROTIZING ARTERITIS; NONHUMAN; PATHOGENESIS; POLYARTERITIS NODOSA; PROGNOSIS; REVIEW; SEPSIS; SMOOTH MUSCLE FIBER; THROMBOSIS; TREATMENT RESPONSE; VASCULAR DISEASE; VASCULAR SURGERY; VASCULITIS; VIRUS LOAD; WOUND HEALING IMPAIRMENT; ANEURYSM; ANIMAL; BLOOD VESSEL; COMPLICATION; HIV INFECTIONS; IMMUNOLOGY; PATHOLOGY; PRACTICE GUIDELINE; SURGERY; VASCULAR ENDOTHELIUM; VASCULITIS, LEUKOCYTOCLASTIC, CUTANEOUS; VIROLOGY;

ANEURYSM; ANIMALS; ATHEROSCLEROSIS; BLOOD VESSELS; ENDOTHELIUM, VASCULAR; HIV INFECTIONS; HUMANS; MYOCYTES, SMOOTH MUSCLE; PRACTICE GUIDELINES AS TOPIC; THROMBOSIS; VASCULAR SURGICAL PROCEDURES; VASCULITIS, LEUKOCYTOCLASTIC, CUTANEOUS;

EID: 84929912300     PISSN: 19951892     EISSN: 16800745     Source Type: Journal    
DOI: 10.5830/CVJA-2015-017     Document Type: Review

References (81)

1. Bennet NJ, Gilroy SA, Bronze MS, Glatt A, Windle ML. HIV disease. emedicine.medscape.com.2011.http://emedicine.medscape.com/article/211316-overview. Accessed December 23/2013.
2. Busari O, Opadijo O, Adeyemi O. Cardiac diseases in HIV and AIDS. Internet J Cardiol 2008; 5(2): 1-13.
3. Mulaudzi TV. HIV-associated vasculopathy. CME 2009; 27(7): 320-322.
4. Robbs JV, Paruk N. Management of HIV vasculopathy - a South African experience. Eur J Vasc Endovasc Surg 2010; 39(Suppl 1): S25-S31.
5. Joshi VV, Pawel B, Connor E, et al. Arteriopathy in children with acquired immune deficiency syndrome. Pediatr Pathol 1987; 7(3): 261-275.
6. Chetty R. Vasculitides associated with HIV infection. J Clin Pathol 2001; 54(4): 275-278.
7. Johnson RM, Barbarini G, Barbaro G. Kawasaki-like syndromes and other vasculitic syndromes in HIV-infected patients. AIDS 2003; 17(Suppl 1): S7-S82.
8. Naidoo NG, Beningfield SJ. Other manifestations of HIV vasculopathy. S Afr J Surg 2009; 47(2): 46-53.
9. Patel N, Patel N, Khan T, Patel N, Espinoza LR. HIV infection and clinical spectrum of associated vaculitides. Curr Rheumatol Rep 2011; 13: 506-512.
10. Stankovic K, Miailhes P, Bessis D, Ferry T, Broussolle C, Séve P. Kawasaki-like syndromes in HIV-infected adults. J Infect 2007; 55(6): 488-494.
11. Woolgar JD, Robbs JV. Vascular surgical complications of the acquired immunodeficiency syndrome. Eur J Vasc Endovasc Surg 2002; 24(6): 473-479.
12. Benjamin LA, Bryer A, Emsley HCA, Khoo S, Solomon T, Conner MD. HIV infection and stroke: current perspectives and future directions. Lancet Neurol 2012; 11(10): 878-890.
13. Guillevin L, Cohen P. Management of virus-induced systemic vasculitides. Curr Rheumatol Rep 2002; 4(1): 60-66.
14. Monseuz JJ, Charniot JC, Escaut L, et al. HIV-associated vascular diseases: structural and functional changes, clinical implications. Int J Cardiol 2009; 133(3): 293-306.
15. Nieuwhof CMG, Damoiseaux J, Tervaert JWC. Successful treatment of cerebral vasculitis in an HIV-positive patient with anti-CD25 treatment. Ann Rheum Dis 2006; 65(12): 1677-1678.
16. Mu H, Chai H, Lin PH, Yao Q, Chen C. Current update on HIV-associated vascular disease and endothelial dysfunction. World J Surg 2007; 31(4): 632-643.
17. Maggi P, Ingrassia F, D'Annunzio M. Endothelial inflammatory disease and cardiovascular risk in HIV patients. HAART Correlated Pathol 2008; 1: 19-25.
18. Schecter AD, Berman AB, Yi L, et al. HIV envelope gp120 activates human smooth muscle cells. Proc Natl Acad Sci USA 2001; 98(18): 10142-10147.
19. Eugenin EA, Morgello S, Klotman ME, et al. Human Immunodeficiency Virus (HIV) infects human arterial smooth muscle cells in vivo and in vitro. Implications for the pathogenesis of HIV-mediated vascular disease. Am J Pathol 2008; 172(4): 1100-1111.
20. Gutierrez J, Glenn M, Isaacson RS, Marr AD, Mash D, Petito C. Thinning of the arterial media layer as a possible preclinical stage in HIV vasculopathy: a pilot study. Stroke 2012; 43(4): 1156-1158.
21. Tilson MD 3rd, Withers L. Arterial aneurysms in HIV patients: molecular mimicry versus direct infection? Ann NY Acad Sci 2006; 1085(Nov): 387-391.
22. Mulaudzi TV, Robbs JV, Pillay W, et al. Thrombectomy in HIV related peripheral arterial thrombosis: a preliminary report. Eur J Vasc Endovasc Surg 2005; 30(1): 102-106.
23. Pipitone N, Salvarani C. The role of infectious agents in the pathogenesis of vasculitis. Best Pract Res Clin Rheumatol 2008; 22(5): 897-911.
24. Du Pont JR, Bonavita JA, DiGiovanni RJ, Spector HB, Nelson SC. Acquired immunodeficiency syndrome and mycotic abdominal aneurysms: a new challenge? Report of a case. J Vasc Surg 1989; 10(3): 254-257.
25. Bayley AC. Surgical pathology of HIV infection: lessons from Africa. Br J Surg 1990; 77(8): 863-868.
26. Heikkinen MA, Dake MD, Alsac J-M, Zarins CK. Multiple HIV-related aneurysms: open and endovascular treatment. J Endovasc Ther 2005; 12(3): 405-410.
27. Kuskov SI. Arterial pseudoaneurysms as the initial clinical manifestitation of HIV Infection (Abstract). East Cent Afr J Surg 2006; 11(1): 94-98.
28. Marks C, Kuskov S. Pattern of arterial aneurysms in acquired immunodeficiency disease. World J Surg 1995; 19(1): 127-132.
29. Nair R, Abdool-Carrim ATO, Chetty R, Robbs JV. Arterial aneurysms in patients infected with human immunodeficiency virus: a distinct clinicopathology entity? J Vasc Surg 1999; 29(4): 600-607.
30. Nair R, Robbs JV, Naidoo NG. Spontaneous carotid artery aneurysms. Br J Surg 2000; 87(2): 186-190.
31. Nair R, Robbs JV, Naidoo NG, Woolgar J. Clinical Profile of HIV-related aneurysms. Eur J Vasc Endovasc Surg 2000; 20(3): 235-240.
32. Woolgar JD, Ray R, Maharaj K, Robbs JV. Colour Doppler and grey scale ultrasound features of HIV-related vascular aneurysms. Br J Radiol 2002; 75(899): 884-888.
33. Demopoulos D, Hendson W, Technau K, Cilliers AM. Vasculopathy in HIV-infected children- a case series. SAfr J Child Health 2009; 3(1): 27-30.
34. Calabrese LH, Estes M, Yen-Lieberman B, et al. Systemic vasculitis in association with human immunodeficiency virus infection. Arthritis Rheum 1989; 32(5): 569-576.
35. Blignaut G, Loggenberg E, de Vries C. The radiological appearance of intracranial aneurysms in adults infected with the human immunodeficiency virus (HIV). S Afr J Rad 2014; 18(1): 1-4.
36. Bonkowsky JL, Christenson JC, Nixon GW, Pavia AT. Cerebral aneurysms in a child with acquired immune deficiency syndrome during rapid immune reconstitution. J Child Neurol 2002; 17: 457-460.
37. Bulsara KR, Raja A, Owen J. HIV and cerebral aneurysms. Neurosurg Rev 2005; 28: 92-95.
38. Julie AA, Erickson JC, Lowry KJ. Cerebral aneurysmal arteriopathy associated with HIV infection in an adult. Clin Infect Dis 2006; 43: e46-e50.
39. Mazzoni P, Chiriboga CA, Millar WS, Rogers A. Intracerebral aneurysms in human immunodeficiency virus infection: case report and literature review. Pediatr Neurol 2000; 23: 252-255.
40. Modi G, Ranchod K, Modi M, Mochan A. Human immunodeficiency virus associated intracranial aneurysms: report of three adult patients with an overview of the literature. J Neurol Neurosurg 2008; 79: 44-46.
41. Mnguni P. Vascular lesions associated with HIV. S Afr J Radiol 2006; 10(4): 14-17.
42. O'Charoen P, Hesselink JR, Healy JF. Cerebral aneurysmal arteriopathy in an adult patient with acquired immunodeficiency syndrome. Am J Neuroradiol 2007; 28: 938-939.
43. Patsalides AD, Wood LV, Atac GK, Butman JA, Patronas NJ. Cerebrovascular Disease in HIV-infected paediatric patients: neuroimaging findings. Am J Radiol 2002; 179: 999-1003.
44. Stanley A, Candy S, Levin C, Heckmann JM. The complexity of HIV vasculopathy. S Afr Med J 2012; 102(6): 474-476.
45. Tipping B, De Villiers L, Candy S, Wainwright H. Stroke caused by human immunodeficiency virus-associated intracranial large-vessel aneurysmal vasculopathy. Arch Neurol 2006; 63: 1640-1642.
46. Chetty R, Batitang S, Nair R. Large artery vasculopathy in HIV-positive patients: another vasculitic enigma. Hum Pathol 2000; 31(3): 374-379.
47. Van Marle J, Tudhope L, Weir G, Botes K. Vascular Disease in HIV/AIDS patients. S Afr Med J 2002; 92(12): 74-78.
48. Botes K, van Marle J. Surgical intervention for HIV related vascular disease. Eur J Vasc Endovasc Surg 2007; 34(4): 390-396.
49. Blyth D. Human immunodeficiency virus disease and cardiac surgery-where are we? SAHeart 2009; 6(4): 210-220.
50. George R, Przybojewski S, Theron S. Endovascular treatment of femoral artery pseudoaneurysm in a HIV positive patient - a case report. Eur J Vasc Endovasc Surg Extra 2007; 13: 79-81.
51. Piccinato CE, Cherri J, Moriya T, Souza AC. Pseudoaneurysms of large arteries associated with AIDS. Sao Paulo Med J/Rev Paul Med 1999; 117(4): 165-170.
52. Padayachy V, Robbs JV. Carotid artery aneurysms in patients with human immunodeficiency virus. J Vasc Surg 2012; 55(2): 331-337.
53. Scholtz L. Vascular manifestations of HIV/AIDS. Cardiovasc Interven Radiol 2004; 27(5): 422-426.
54. Delgado Almandoz JE, Crandall BM, Fease JL, Scholz JM, Anderson RE, Kadkhodayan Y, Tubman DE. Successful endovascular treatment of three fusiform cerebral aneurysms with the pipeline embolization device in a patient with dilating HIV vasculopathy. J Neurointerv Surg 2014; 6(2): e12.
55. Euringer W, Südkamp M, Rylski B, Blanke P. Endovascular treatment of multiple HIV-related aneurysms using multilayer stents. Cardiovasc Interven Radiol 2012; 35: 945-949.
56. Sfyroeras GS, Dalainas I, Giannakopoulos TG, Antonopoulos K, Kakisis JD, Liapis CD. Flow-diverting stents for the treatment of arterial aneurysms. J Vasc Surg 2012; 56: 839-846.
57. Lin PH, Bush RL, Yao Q, et al. Abdominal aortic surgery in patients with human immunodeficiency virus infection. Am J Surg 2004; 188(6): 690-697.
58. Van Marle J, Mistry PP, Botes K. HIV-occlusive vascular disease. S Afr J Surg 2009; 47(2): 36-42.
59. Nair R, Robbs JV, Chetty R, Naidoo NG, Woolgar J. Occlusive arterial disease in HIV-infected patients: a preliminary report. Eur J Vasc Endovasc Surg 2000; 20(4): 353-357.
60. Robbs JV. Pathogenesis and pathology of HIV-related large-vessel disease. S Afr J Surg 2009; 47(2): 44-45.
61. Micheletti RG, Fishbein GA, Currier JS, Singer EJ, Fishbein MC. Calcification of the internal elastic lamina of coronary arteries. Mod Pathol 2008; 21(8): 1019-1028.
62. Nair R, Chetty R, Woolgar J, Naidoo NG, Robbs JV. Spontaneous arteriovenous fistula resulting from HIV arteritis. J Vasc Surg 2000; 33(1): 186-187.
63. Felicio AC, Silva GS, dos Santos WAC, Pieri A, Gabbai AA, Massaro AR. Spontaneous artery dissection in a patient with human immunodeficiency virus (HIV) infection. Arq Neuropsiquiatr 2006; 64(2A): 306-308.
64. Barry R. The future of HIV vasculopathy when our patients are on antiretroviral therapy. S Afr J Surg 2009; 47(2): 58-60.
65. Barry R. How does vascular disease associated with retroviral infection differ from atherosclerosis? S Afr J Anaesthes Analg 2010; 16(1): 51-53.
66. Friis-Møller N, Sabin CA, Weber R, et al. Data collection on adverse events of anti-HIV drugs (DAD) study group. Combination antiretroviral therapy and the risk of myocardial infarction. N Engl J Med 2003; 349(21); 1993-2003.
67. Ho JE, Hsue PY. Cardiovascular manifestations of HIV infection. Heart 2009; 95(14): 1193-1202.
68. Lo J, Grinspoon S. Cardiovascular disease in HIV-infected patients: does HIV infection in and of itself increase cardiovascular risk? Curr Opin HIV AIDS 2008; 3(3): 207-213.
69. Maggi P, Maserati R, Antonelli G. Atherosclerosis in HIV patients: a new face for an old disease? AIDS Rev 2006; 8(4): 204-219.
70. Niaura R, Shadel WG, Morrow K, Tashima K, Flanigan T, Abrams DB. Human immunodeficiency virus infection, AIDS, and smoking cessation: the time is now. Clin Infect Dis 2000; 31(3): 808-812.
71. Hakeem A, Bhatti S, Cilingiroglu M. The spectrum of atherosclerotic coronary artery disease in HIV patients. Curr Atheroscler Rep 2010; 12(2): 119-124.
72. Madiba TE, Muckart DJJ, Thomson SR. Human immunodeficiency disease: how should it affect surgical decision making? World J Surg 2009; 33(5): 899-909.
73. Fourie CMT, Van Rooyen JM, Schutte AE. HIV infection and cardiovascular risk in black South Africans. Cardiovasc J Afr 2011; 22(3): 117-118.
74. Fourie C, Van Rooyen J, Pieters M, Conradie K, Hoekstra T, Schutte A. Is HIV-1 infection associated with endothelial dysfunction in a population of African ancestry in South Africa? Cardiovasc J Afr 2011; 22(3): 134-140.
75. Periard D, Cavassini M, Taffé P, et al. Swiss HIV Cohort Study. High prevalence of peripheral arterial disease in HIV-infected persons. Clin Infect Dis 2008; 46: 761-767.
76. Hammer SM, Eron JJ Jr, Reiss P, et al. International AIDS Society-USA. Antiretroviral treatment of adult HIV infection: 2008 recommendations of the International AIDS Society-USA. J Am Med Assoc 2008; 300(5): 555-570.
77. Paraskevas KI, Hamilton G, Mikhailidis DP. Statins: an essential component in the management of carotid artery disease. J Vasc Surg 2007; 46(2): 373-386.
78. Paraskevas KI, Katsiki N, Tzovaras AA, Koupidis SA, Mikhailidis DP. Peripheral arterial disease and HIV-positive patients. Angiology 2011; 62(1): 7-9.
79. Triant VA, Grinspoon SK. Immune dysregulation and vascular risk in HIV-infected patients: implications for clinical care. J Infect Dis 2011; 203(4): 439-441.
80. Gilliam BL, Riedel DG, Redfield RR. Clinical use of CCR5 inhibitors in HIV and beyond. J Transl Med 2010; 9(Suppl): S9-S14.
81. Qaqa AY, DeBari VA, Isbitan A, et al. The role of post-exercise measurements in the diagnosis of peripheral arterial disease in HIV-infected patients. Angiology 2011; 62(1): 10-14.